Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anaplastic Astrocytoma
- Glioblastoma Multiforme
- High Grade Glioma
- Malignant Glioma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 13 years and 99 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01808820
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Macarena De La Fuente, MD University of Miami
Get Well Soon